Irisin Alleviates Cognitive Impairment by Inhibiting AhR/NF-κB-NLRP3-Mediated Pyroptosis of Hippocampal Neurons in Chronic Kidney Disease
2024

Irisin Helps Improve Memory Problems in Kidney Disease

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Jialing Zhang, Dong Xingtong, Pang Qi, Aihua Zhang

Primary Institution: Xuanwu Hospital, Capital Medical University, Beijing, China

Hypothesis

Irisin could inhibit pyroptosis by regulating AhR and NF-κB pathway to improve CKD-associated cognitive dysfunction.

Conclusion

Irisin alleviates cognitive impairment by inhibiting pyroptosis of hippocampal neurons in chronic kidney disease.

Supporting Evidence

  • Irisin treatment improved cognitive function in CKD mice.
  • CKD mice showed increased levels of pyroptosis-related proteins.
  • Irisin reduced the levels of IL-1β induced by indoxyl sulfate.
  • AhR and NF-κB signaling were upregulated in CKD mice.
  • Inhibition of AhR and NF-κB reduced pyroptosis in vitro.

Takeaway

Irisin is a substance that can help the brain work better in people with kidney problems by stopping certain harmful processes in brain cells.

Methodology

A CKD mice model was established, cognitive function was assessed via the novel object recognition test, and pyroptosis-related protein expression was analyzed using western blotting.

Limitations

The mechanism of knocking down key molecules on the pyroptosis signaling are warranted to validate results; antagonists in CKD mice models were absent.

Participant Demographics

Male C57BL/6 mice aged 6 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/mi/2662362

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication